BCL2 and periodontitis: The results of molecular dynamics simulations suggested that the compounds were tightly bound and the complex was stable, suggesting that modulation of BCL2 may be a potential mechanism of action for the treatment of periodontitis with the Asarum–Angelica drug pair.